Skip to content

Pediatric Hypertension

Learning Objectives

Core Knowledge & Clinical Reasoning

  • [ ] Apply 2017 AAP BP classification criteria (elevated BP, Stage 1, Stage 2) using appropriate tables
  • [ ] Determine when to transition from pediatric percentile-based to adult threshold-based criteria (age ≥13)
  • [ ] Analyze clinical and laboratory findings to differentiate primary from secondary hypertension
  • [ ] Evaluate indications for ambulatory BP monitoring (ABPM) and interpret results

Pharmacotherapy

  • [ ] Select appropriate first-line antihypertensive therapy based on etiology and comorbidities
  • [ ] Formulate dose titration and monitoring plan for antihypertensive medications

Communication & Counseling

  • [ ] Counsel families on lifestyle modifications (diet, exercise, weight management, sodium restriction)
  • [ ] Discuss long-term cardiovascular risk associated with childhood hypertension

Systems-Based Practice

  • [ ] Coordinate evaluation for secondary causes with appropriate subspecialties (nephrology, endocrine)
  • [ ] Ensure appropriate BP measurement technique is used (correct cuff size, positioning)

Key Guidelines

2017 AAP Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents Pediatrics. 2017;140(3):e20171904

Key Changes from 2004 Fourth Report

  1. "Elevated BP" replaces "prehypertension"
  2. NEW normative BP tables based on normal-weight children only
  3. Simplified screening table for primary care
  4. Age ≥13 years: Use adult criteria (120/80 threshold)
  5. BP screening only at preventive care visits
  6. Expanded role for ABPM
  7. Updated medication recommendations
  8. Treatment goal: <90th percentile (or <130/80 for adolescents ≥13)

BP Classification

Children 1-12 Years (Use Pediatric Tables)

Category Systolic AND/OR Diastolic
Normal <90th percentile
Elevated BP ≥90th to <95th percentile OR 120/<80 (whichever is lower)
Stage 1 HTN ≥95th percentile to <95th + 12 mmHg OR 130/80 to 139/89
Stage 2 HTN ≥95th percentile + 12 mmHg OR ≥140/90

Adolescents ≥13 Years (Use Adult Criteria)

Category Systolic Diastolic
Normal <120 AND <80
Elevated BP 120-129 AND <80
Stage 1 HTN 130-139 OR 80-89
Stage 2 HTN ≥140 OR ≥90

Measurement Technique

  • Appropriate cuff size (bladder width 40% of arm circumference)
  • Seated, back supported, feet on floor
  • Right arm preferred (coarctation detection)
  • 3-5 minutes of rest before measurement
  • Auscultatory method preferred for diagnosis confirmation
  • Oscillometric devices require validation

Evaluation

When to Evaluate

  • Elevated BP on 3 separate occasions
  • Stage 2 HTN at initial visit warrants immediate evaluation

Initial Workup (All Children with HTN)

  • History: diet, activity, sleep, medications, family history
  • Physical exam: including 4-extremity BP (rule out coarctation)
  • Labs: BMP, urinalysis, lipid panel, CBC
  • Renal ultrasound (if <6 years or abnormal UA/renal function)

Extended Workup (Secondary HTN Suspected)

  • Plasma renin/aldosterone
  • Urine catecholamines
  • Thyroid function
  • Drug screen
  • Polysomnography (if OSA suspected)
  • Renal artery Doppler or CTA/MRA

ABPM Indications

  • Confirm HTN before starting therapy
  • White coat hypertension suspected
  • Masked hypertension suspected
  • High-risk conditions (CKD, diabetes, s/p CoA repair)
  • Assess efficacy of antihypertensive treatment
  • Clinical symptoms suggesting hypertension

ABPM Interpretation

  • Ambulatory HTN: Mean SBP or DBP ≥95th percentile
  • Load: % readings above threshold (>25% abnormal)
  • Dipping: Normal = 10-20% drop during sleep

Management

Lifestyle Modifications (All Patients)

  • Weight loss if overweight/obese
  • DASH diet
  • Regular aerobic exercise (30-60 min/day)
  • Limit sedentary activities (<2 hrs screen time)
  • Adequate sleep

Pharmacotherapy Indications

  • Stage 1 HTN + symptoms or target organ damage
  • Stage 2 HTN
  • Stage 1 HTN persistent despite lifestyle modifications
  • HTN with diabetes, CKD, or heart disease

First-Line Medications

Class Examples Notes
ACE inhibitors Lisinopril, enalapril Preferred if proteinuria, DM
ARBs Losartan ACEi alternative
CCBs Amlodipine Good for primary HTN
Thiazide diuretics Chlorthalidone, HCTZ Good for primary HTN

Treatment Goals

  • Children: <90th percentile
  • Adolescents ≥13: <130/80
  • CKD with proteinuria: <50th percentile

2023 ESH Guidelines Comparison

Feature AAP 2017 ESH 2023
Adult criteria age ≥13 years ≥16 years
BP tables Normal-weight only Include overweight
Classification Similar Similar

Board Pearls

Pearl: Use adult criteria (120/80) starting at age 13

Per 2017 AAP guidelines; ESH uses 16 years

Pearl: 2017 tables use NORMAL-WEIGHT children only

Major change from 2004 Fourth Report

Pearl: ABPM before starting medication

Confirm diagnosis; rule out white coat HTN

Self-Assessment

Q1: A 10-year-old has BP readings of 122/76, 118/74, and 120/78 on three visits. Height is 50th percentile. How is this classified?

Answer **Answer**: Elevated BP **Rationale**: For children <13 years, use the pediatric tables. The 95th percentile for a 10-year-old at 50th height percentile is approximately 122/82. Readings consistently ≥90th percentile but <95th percentile = Elevated BP. Note: if 120/<80 is lower than the 90th percentile, use 120/<80 as the threshold.

Q2: A 15-year-old has BP of 134/82. What is the classification and initial management?

Answer **Answer**: Stage 1 hypertension; lifestyle modifications with repeat measurement **Rationale**: At ≥13 years, use adult criteria. 130-139/80-89 = Stage 1 HTN. Initial management includes lifestyle modifications with repeat BP measurements. If persistent without symptoms or target organ damage, may observe with lifestyle changes before medication.

References

  • Flynn JT, et al. Pediatrics. 2017;140(3):e20171904
  • ESH 2023 Guidelines. J Hypertens. 2023